SMIM22
gene geneOn this page
Also known as CASIMO1
Summary
SMIM22 (small integral membrane protein 22, HGNC:48329) is a protein-coding gene on chromosome 16p13.3, encoding Small integral membrane protein 22 (K7EJ46). May modulate lipid droplet formation throught interaction with SQLE.
Involved in several processes, including lipid droplet formation; positive regulation of cell migration; and regulation of actin cytoskeleton organization. Predicted to be located in late endosome and membrane.
Source: NCBI Gene 440335 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 1 total
- MANE Select transcript:
NM_001253794
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:48329 |
| Approved symbol | SMIM22 |
| Name | small integral membrane protein 22 |
| Location | 16p13.3 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | CASIMO1 |
| Ensembl gene | ENSG00000267795 |
| Ensembl biotype | protein_coding |
| Entrez | 440335 |
Gene structure
Transcript identifiers
Ensembl transcripts: 15 — 12 protein_coding, 3 retained_intron
ENST00000586005, ENST00000586440, ENST00000588500, ENST00000588606, ENST00000588894, ENST00000589327, ENST00000589721, ENST00000591004, ENST00000591870, ENST00000615471, ENST00000615889, ENST00000904659, ENST00000904660, ENST00000904661, ENST00000937276
RefSeq mRNA: 4 — MANE Select: NM_001253794
NM_001253790, NM_001253791, NM_001253793, NM_001253794
CCDS: CCDS59258, CCDS59259
Canonical transcript exons
ENST00000586005 — 4 exons
| Exon | Start | End |
|---|---|---|
| ENSE00002761834 | 4795715 | 4795858 |
| ENSE00002883420 | 4795369 | 4795449 |
| ENSE00002889987 | 4795948 | 4796048 |
| ENSE00002945716 | 4796190 | 4796491 |
Expression profiles
Bgee: expression breadth ubiquitous, 159 present calls, max score 99.38.
FANTOM5 (CAGE): breadth broad, TPM avg 3.3786 / max 101.1040, expressed in 257 samples.
FANTOM5 promoters (5 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 152499 | 2.7529 | 247 |
| 152498 | 0.5814 | 168 |
| 152495 | 0.0203 | 3 |
| 152496 | 0.0152 | 3 |
| 152497 | 0.0088 | 3 |
Top tissues by expression
249 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| mucosa of transverse colon | UBERON:0004991 | 99.38 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 98.39 | gold quality |
| right uterine tube | UBERON:0001302 | 97.98 | gold quality |
| rectum | UBERON:0001052 | 97.93 | gold quality |
| body of pancreas | UBERON:0001150 | 97.01 | gold quality |
| pancreas | UBERON:0001264 | 93.43 | gold quality |
| islet of Langerhans | UBERON:0000006 | 92.02 | gold quality |
| transverse colon | UBERON:0001157 | 91.67 | gold quality |
| small intestine Peyer’s patch | UBERON:0003454 | 91.31 | gold quality |
| minor salivary gland | UBERON:0001830 | 91.09 | gold quality |
| mucosa of sigmoid colon | UBERON:0004993 | 90.96 | silver quality |
| ileal mucosa | UBERON:0000331 | 90.83 | gold quality |
| gall bladder | UBERON:0002110 | 90.68 | gold quality |
| colonic mucosa | UBERON:0000317 | 90.30 | gold quality |
| saliva-secreting gland | UBERON:0001044 | 90.06 | gold quality |
| left testis | UBERON:0004533 | 90.01 | gold quality |
| right testis | UBERON:0004534 | 89.82 | gold quality |
| small intestine | UBERON:0002108 | 89.36 | gold quality |
| adenohypophysis | UBERON:0002196 | 89.16 | gold quality |
| body of stomach | UBERON:0001161 | 89.05 | gold quality |
| duodenum | UBERON:0002114 | 87.20 | gold quality |
| pituitary gland | UBERON:0000007 | 86.93 | gold quality |
| pancreatic ductal cell | CL:0002079 | 86.63 | gold quality |
| stomach | UBERON:0000945 | 86.59 | gold quality |
| testis | UBERON:0000473 | 86.40 | gold quality |
| metanephros cortex | UBERON:0010533 | 86.08 | gold quality |
| mouth mucosa | UBERON:0003729 | 84.76 | gold quality |
| lower esophagus mucosa | UBERON:0035834 | 84.65 | gold quality |
| upper lobe of left lung | UBERON:0008952 | 83.28 | gold quality |
| mucosa of stomach | UBERON:0001199 | 83.12 | gold quality |
Single-cell (SCXA)
Detected in 11 experiment(s), a significant marker in 9.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-MTAB-8410 | yes | 1452.77 |
| E-MTAB-6308 | yes | 932.72 |
| E-HCAD-1 | yes | 81.06 |
| E-CURD-114 | yes | 64.28 |
| E-MTAB-10287 | yes | 52.45 |
| E-MTAB-6701 | yes | 22.69 |
| E-HCAD-10 | yes | 21.61 |
| E-ANND-3 | yes | 18.39 |
| E-GEOD-130148 | yes | 11.85 |
| E-GEOD-125970 | no | 28.56 |
| E-HCAD-31 | no | 2.35 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
7 targeting SMIM22, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-7-5P | 99.67 | 70.53 | 1809 |
| HSA-MIR-6126 | 99.62 | 68.09 | 996 |
| HSA-MIR-4439 | 98.53 | 67.53 | 793 |
| HSA-MIR-6816-5P | 98.46 | 64.35 | 364 |
| HSA-MIR-5089-5P | 98.45 | 66.06 | 1388 |
| HSA-MIR-484 | 98.16 | 66.92 | 1074 |
| HSA-MIR-6857-3P | 96.70 | 65.43 | 915 |
Cross-species orthologs
3 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | si:ch1073-443f11.2 | ENSDARG00000105068 |
| mus_musculus | Smim22 | ENSMUSG00000096215 |
| rattus_norvegicus | Smim22 | ENSRNOG00000080339 |
Protein
Protein identifiers
Small integral membrane protein 22 — K7EJ46 (reviewed: K7EJ46)
Alternative names: Cancer-associated small integral membrane open reading frame 1
All UniProt accessions (2): A0A4V7I672, K7EJ46
UniProt curated annotations — full annotation on UniProt →
Function. May modulate lipid droplet formation throught interaction with SQLE.
Subunit / interactions. Interacts with CANX and DDOST. Interacts with SQLE; this interaction modulates lipid droplet formation.
Subcellular location. Membrane. Late endosome.
Induction. Up-regulated in breast cancer.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| K7EJ46-3 | 3 | yes |
| K7EJ46-2 | 2 |
RefSeq proteins (4): NP_001240719, NP_001240720, NP_001240722, NP_001240723* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR031671 | SMIM5/18/22 | Family |
| IPR053081 | SIM_Modulators | Family |
Pfam: PF15831
UniProt features (5 total): chain 1, transmembrane region 1, region of interest 1, compositionally biased region 1, splice variant 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-K7EJ46-F1 | 76.07 | 0.23 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 47 (showing top):
GSE45365_NK_CELL_VS_CD8_TCELL_DN, GOZGIT_ESR1_TARGETS_DN, GOBP_REGULATION_OF_ACTIN_FILAMENT_BASED_PROCESS, SENGUPTA_NASOPHARYNGEAL_CARCINOMA_DN, GOBP_REGULATION_OF_CELL_CYCLE, GOBP_ORGANELLE_ASSEMBLY, GOBP_REGULATION_OF_CYTOSKELETON_ORGANIZATION, DODD_NASOPHARYNGEAL_CARCINOMA_DN, PANGAS_TUMOR_SUPPRESSION_BY_SMAD1_AND_SMAD5_UP, GOBP_LIPID_DROPLET_ORGANIZATION, YANG_BCL3_TARGETS_UP, NFE2L2.V2, GOBP_LIPID_DROPLET_FORMATION, DURANTE_ADULT_OLFACTORY_NEUROEPITHELIUM_RESPIRATORY_CILIATED_CELLS, BUSSLINGER_GASTRIC_MATURE_PIT_CELLS
GO Biological Process (5): positive regulation of cell migration (GO:0030335), regulation of actin cytoskeleton organization (GO:0032956), regulation of cell population proliferation (GO:0042127), regulation of cell cycle (GO:0051726), lipid droplet formation (GO:0140042)
GO Molecular Function (1): protein binding (GO:0005515)
GO Cellular Component (3): late endosome (GO:0005770), membrane (GO:0016020), endosome (GO:0005768)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| regulation of cellular process | 2 |
| cell migration | 1 |
| regulation of cell migration | 1 |
| positive regulation of cell motility | 1 |
| actin cytoskeleton organization | 1 |
| regulation of actin filament-based process | 1 |
| regulation of cytoskeleton organization | 1 |
| cell population proliferation | 1 |
| cell cycle | 1 |
| lipid storage | 1 |
| lipid droplet organization | 1 |
| membraneless organelle assembly | 1 |
| binding | 1 |
| endosome | 1 |
| cellular anatomical structure | 1 |
| endomembrane system | 1 |
| cytoplasmic vesicle | 1 |
Protein interactions and networks
STRING
174 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| SMIM22 | SQLE | Q14534 | 816 |
| SMIM22 | NBDY | A0A0U1RRE5 | 600 |
| SMIM22 | SMIM30 | A4D0T7 | 540 |
| SMIM22 | MRLN | P0DMT0 | 476 |
| SMIM22 | REPS2 | Q8NFH8 | 376 |
| SMIM22 | C8orf89 | P0DMQ9 | 366 |
| SMIM22 | STRIT1 | P0DN84 | 353 |
| SMIM22 | TMEM233 | B4DJY2 | 349 |
| SMIM22 | SNN | O75324 | 348 |
| SMIM22 | HRCT1 | Q6UXD1 | 348 |
| SMIM22 | ROGDI | Q9GZN7 | 339 |
| SMIM22 | NINL | Q9Y2I6 | 324 |
| SMIM22 | UBAP1 | Q9NZ09 | 322 |
| SMIM22 | SPAAR | A0A1B0GVQ0 | 310 |
| SMIM22 | MTLN | Q8NCU8 | 308 |
IntAct
1 interactions, top by confidence:
ESM2 similar proteins: A0A1B0GST9, A0A1B0GTU2, A0A1B0GV90, A0A590UK83, A2RRL7, A7S641, A8WG88, A9JTJ0, B9X187, K7EJ46, O00168, O08589, O13001, P0C2S0, P15383, P41237, P56513, P60606, P63160, P63161, Q04645, Q04646, Q04679, Q04680, Q0P467, Q28EH9, Q3SZX0, Q3UJ81, Q3URE8, Q3ZBP2, Q4LDR2, Q4R6L9, Q502I1, Q592E4, Q5XF36, Q6AXF6, Q6NWH5, Q6PBK8, Q6Q3F5, Q71RC9
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
1 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 0 |
| Likely benign | 0 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
974 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 16:4794951:GGGA:G | acceptor_gain | 1.0000 |
| 16:4794976:T:TA | acceptor_gain | 1.0000 |
| 16:4794985:C:CA | acceptor_gain | 1.0000 |
| 16:4794986:G:A | acceptor_gain | 1.0000 |
| 16:4795854:CATGG:C | donor_gain | 1.0000 |
| 16:4795855:ATGG:A | donor_gain | 1.0000 |
| 16:4795855:ATGGG:A | donor_loss | 1.0000 |
| 16:4795856:TGG:T | donor_gain | 1.0000 |
| 16:4795856:TGGGT:T | donor_loss | 1.0000 |
| 16:4795857:GG:G | donor_gain | 1.0000 |
| 16:4795857:GGG:G | donor_gain | 1.0000 |
| 16:4795858:GG:G | donor_gain | 1.0000 |
| 16:4795858:GGT:G | donor_loss | 1.0000 |
| 16:4795859:G:GG | donor_gain | 1.0000 |
| 16:4795860:T:A | donor_loss | 1.0000 |
| 16:4795942:CCCCA:C | acceptor_loss | 1.0000 |
| 16:4795943:CCCAG:C | acceptor_loss | 1.0000 |
| 16:4795944:CCA:C | acceptor_loss | 1.0000 |
| 16:4795945:CAGGC:C | acceptor_loss | 1.0000 |
| 16:4795946:A:AC | acceptor_loss | 1.0000 |
| 16:4795946:A:AG | acceptor_gain | 1.0000 |
| 16:4795947:G:GA | acceptor_gain | 1.0000 |
| 16:4795947:GGC:G | acceptor_gain | 1.0000 |
| 16:4794947:ATCAG:A | acceptor_gain | 0.9900 |
| 16:4795139:A:AG | acceptor_gain | 0.9900 |
| 16:4795140:T:G | acceptor_gain | 0.9900 |
| 16:4795749:A:AG | acceptor_gain | 0.9900 |
| 16:4795750:G:GG | acceptor_gain | 0.9900 |
| 16:4795946:AG:A | acceptor_gain | 0.9900 |
| 16:4795947:GG:G | acceptor_gain | 0.9900 |
AlphaMissense
0 scored. Top likely-pathogenic:
dbSNP variants (sampled 300 via entrez): RS1000266886 (16:4789191 T>C), RS1000340856 (16:4789395 G>A,T), RS1000631884 (16:4790247 G>C), RS1000663083 (16:4790407 T>A), RS1000905336 (16:4795500 G>A), RS1000930505 (16:4791147 G>A), RS1001090054 (16:4787243 C>A), RS1001532183 (16:4796812 C>T), RS1001570432 (16:4792858 C>A,G,T), RS1001979465 (16:4793988 T>G), RS1002030212 (16:4789727 G>A,C), RS1002061568 (16:4789929 T>C), RS1002191675 (16:4791494 A>G), RS1002245413 (16:4791646 C>A,G), RS1002404184 (16:4787728 T>C,G)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
9 total (human), top 9 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Tobacco Smoke Pollution | affects expression, decreases expression | 2 |
| arsenite | affects binding, increases reaction | 1 |
| jinfukang | affects cotreatment, decreases expression | 1 |
| Air Pollutants | increases abundance, increases expression | 1 |
| Cisplatin | decreases expression, affects cotreatment | 1 |
| Silicon Dioxide | affects expression | 1 |
| Smoke | increases abundance, increases expression | 1 |
| Tretinoin | decreases expression | 1 |
| Permethrin | increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.